Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

GRISEOFULVIN

GRISEOFULVIN, MICROSIZE

Standard Dose
500MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview GRISEOFULVIN is listed in Drugs@FDA under application 202482 (ANDA).

Marketing status: Prescription Active ingredient GRISEOFULVIN, MICROSIZE Form and strength TABLET;ORAL - 500MG Sponsor SIGMAPHARM LABS LLC Submission history Latest submission status date: 2012-10-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview GRISEOFULVIN is listed in Drugs@FDA under application 202482 (ANDA). Marketing status: Prescription Active ingredient GRISEOFULVIN, MICROSIZE Form and strength TABLET;ORAL - 500MG Sponsor SIGMAPHARM LABS LLC Submission history Latest submission status date: 2012-10-22 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.